Summit Therapeutics (SMMT) News Today $22.19 +0.63 (+2.92%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMMT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's WhyJune 10 at 11:35 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 10 at 9:00 AM | globenewswire.comEquities Analysts Set Expectations for SMMT FY2026 EarningsSummit Therapeutics Inc. (NASDAQ:SMMT - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Summit Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will post earnings of ($0.62) per shaJune 10 at 8:30 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 7 at 10:00 AM | prnewswire.comSummit Therapeutics Inc. (NASDAQ:SMMT) Receives $37.40 Average PT from AnalystsJune 7 at 1:25 AM | americanbankingnews.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 6, 2025 | globenewswire.comSummit Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceJune 5, 2025 | finance.yahoo.comWhy Summit Therapeutics Inc. (SMMT) Crashed On WednesdayJune 5, 2025 | msn.comAmeriprise Financial Inc. Acquires New Stake in Summit Therapeutics Inc. (NASDAQ:SMMT)Ameriprise Financial Inc. acquired a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 22,735 shares of the company's stock, valued at approximately $406,000. A number of other hedge fundsJune 5, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 3.6% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Trading Down 3.6% - Here's WhyJune 4, 2025 | marketbeat.comWhy Summit Therapeutics Inc. (SMMT) Skyrocketed On TuesdayJune 4, 2025 | msn.comSummit Therapeutics Inc. (NASDAQ:SMMT) Receives Average Rating of "Buy" from AnalystsShares of Summit Therapeutics Inc. (NASDAQ:SMMT - Get Free Report) have been assigned an average rating of "Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Ten analysts have rated the stock with a buy recommendation and one has given a strong buy recomJune 4, 2025 | marketbeat.comJMP Securities Reiterates Market Outperform Rating for Summit Therapeutics (NASDAQ:SMMT)June 4, 2025 | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase - Should You Buy?Summit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase - What's Next?June 3, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's WhySummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's WhyJune 3, 2025 | marketbeat.comSummit Therapeutics: Market Overreaction Creates OpportunityJune 2, 2025 | seekingalpha.comSummit Therapeutics (NASDAQ:SMMT) Earns "Market Outperform" Rating from JMP SecuritiesJMP Securities reaffirmed a "market outperform" rating and issued a $40.00 price objective on shares of Summit Therapeutics in a research note on Monday.June 2, 2025 | marketbeat.comIs Beaten-Down Summit Therapeutics Stock a Bad-News Buy?June 2, 2025 | fool.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Nuveen Asset Management LLCNuveen Asset Management LLC lessened its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 13.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 234,426 shares of the company's stoJune 1, 2025 | marketbeat.comSummit Therapeutics Target of Unusually Large Options Trading (NASDAQ:SMMT)Summit Therapeutics Inc. (NASDAQ:SMMT - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock investors acquired 14,375 call options on the company. This is an increase of 111% compared to the average daily volume of 6,798 call options.May 31, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Should You Sell?Summit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Here's What HappenedMay 31, 2025 | marketbeat.comWhy Summit Therapeutics Inc. (SMMT) Crashed On FridayMay 31, 2025 | msn.comJefferies Financial Group Inc. Purchases Shares of 45,001 Summit Therapeutics Inc. (NASDAQ:SMMT)Jefferies Financial Group Inc. purchased a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 45,001 shares of the company's stock, valued at approMay 31, 2025 | marketbeat.comSummit Therapeutics Target of Unusually High Options Trading (NASDAQ:SMMT)May 31, 2025 | americanbankingnews.comSummit Therapeutics stock dips after clinical trial resultsMay 30, 2025 | investing.comSummit Therapeutics Shares Slip Following Mixed Results from Lung Cancer TrialMay 30, 2025 | msn.comSummit Therapeutics Stock Tumbles On Oncology Drug Trial Data, Retail Flags ‘Insane’ ValuationMay 30, 2025 | msn.comSummit claims late-stage trial win for lung cancer therapyMay 30, 2025 | msn.comWhy is Summit stock in selloff after late-stage trial data for lead asset?May 30, 2025 | msn.comSummit Therapeutics: Moving Stock To 'Hold' Rating After Phase 3 HARMONi Data ReleaseMay 30, 2025 | seekingalpha.comWhy Summit Therapeutics Plunged TodayMay 30, 2025 | fool.comSummit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.May 30, 2025 | barrons.comSummit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival EndpointMay 30, 2025 | benzinga.comGF Fund Management CO. LTD. Purchases Shares of 16,905 Summit Therapeutics Inc. (NASDAQ:SMMT)GF Fund Management CO. LTD. acquired a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 16,905 shares of the company's stock, valued atMay 27, 2025 | marketbeat.com25,000 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Acquired by Toronto Dominion BankToronto Dominion Bank purchased a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 25,000 shares of the company's stock, valued at approximately $446,00May 27, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 24.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 64,717 sharesMay 27, 2025 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Stock Holdings Increased by Bank of America Corp DEBank of America Corp DE increased its position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 10.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 431,568 shares of the company's stock aMay 27, 2025 | marketbeat.comNeo Ivy Capital Management Buys Shares of 209,577 Summit Therapeutics Inc. (NASDAQ:SMMT)Neo Ivy Capital Management bought a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 209,577 shares of the company's stock, valued at aMay 25, 2025 | marketbeat.com3 High-Flying Stocks That Could Soar Even MoreMay 24, 2025 | fool.comTema Etfs LLC Purchases New Stake in Summit Therapeutics Inc. (NASDAQ:SMMT)Tema Etfs LLC purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 26,641 shares of the company's stock, valued at approxiMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Has $5.56 Million Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)Rafferty Asset Management LLC increased its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 187.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 311,692 shares of the company's stock after acqMay 20, 2025 | marketbeat.comDeutsche Bank AG Has $8.55 Million Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Deutsche Bank AG lifted its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 20.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 478,808 shares of the company's stock after buying an additional 81,130 sharMay 19, 2025 | marketbeat.comGot $100? 3 Top Growth Stocks to Buy That Could Double Your MoneyMay 18, 2025 | fool.comJefferies Financial Group Inc. Acquires Shares of 45,001 Summit Therapeutics Inc. (NASDAQ:SMMT)Jefferies Financial Group Inc. bought a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 45,001 shares of the company's stock, valued aMay 18, 2025 | marketbeat.comNorthern Trust Corp Has $15.55 Million Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Northern Trust Corp raised its position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 871,402 shares of the company's stock afterMay 17, 2025 | marketbeat.comDimensional Fund Advisors LP Acquires 160,592 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Dimensional Fund Advisors LP boosted its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 358.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 205,337 shares of the company's stock after aMay 16, 2025 | marketbeat.comStockNews.com Upgrades Summit Therapeutics (NASDAQ:SMMT) to "Hold"StockNews.com upgraded shares of Summit Therapeutics from a "sell" rating to a "hold" rating in a report on Tuesday.May 15, 2025 | marketbeat.comBNP Paribas Financial Markets Invests $8.80 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)BNP Paribas Financial Markets purchased a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 493,189 shares of the company'sMay 14, 2025 | marketbeat.comHsbc Holdings PLC Invests $188,000 in Summit Therapeutics Inc. (NASDAQ:SMMT)Hsbc Holdings PLC acquired a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,700 shares of the company's stock, valued at aMay 13, 2025 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.380.68▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼137▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Intra-Cellular Therapies News Today Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMMT Stock Free SMMT Stock Alerts